Navigation Links
Abbott Reports 16 Percent Earnings Growth in First Quarter; Confirms Double-Digit Earnings Growth Outlook for 2009
Date:4/15/2009

cer cells, enhancing the effectiveness of current cancer therapies.
  • Neuroscience
    • Abbott is conducting innovative research in neuroscience, where we have developed compounds that target receptors in the brain that help regulate mood, memory and other neurological functions to address conditions such as attention deficit hyperactivity disorder, Alzheimer's disease and schizophrenia.
  • Immunology
    • Abbott's scientific experience with the anti-TNF biologic HUMIRA serves as a strong foundation for our continuing research in immunology. HUMIRA has several indications in Phase III including ulcerative colitis and pediatric Crohn's disease. Also in Phase III is ABT-874, Abbott's anti-IL 12/23 biologic for psoriasis and Crohn's disease. We are also working to advance development of our early discovery programs, including oral DMARD therapies, as well as other potential biologic targets.
    • Additionally, our proprietary DVD-ig technology represents an innovative approach that can target multiple disease-causing antigens with a single biologic agent.
  • Hepatitis C
    • Abbott's antiviral program is focused on the treatment of hepatitis C, a disease that affects more than 180 million people worldwide. Abbott's broad-based hepatitis C program includes our partnership with Enanta Pharmaceuticals to develop protease inhibitors as well as our internal polymerase inhibitor program. Abbott has three HCV compounds in clinical development.
  • Vascular Devices
    • XIENCE PRIME - Abbott's next-generation DES that capitalizes on the proven attributes of XIENCE V while improving deliverability, especially in longer lengths and complex anatomy. We expect to launch XIENCE PRIME in Europe by year-end 2009.'/>"/>

    SOURCE Abbott
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

    Related medicine news :

    1. Abbott Initiates U.S. Study of Absolute Pro(TM) Peripheral Stent System for Iliac Artery Disease
    2. Abbott Hosts Conference Call for First-Quarter Earnings
    3. Abbott Launches VOYAGER(TM) NC Coronary Balloon Catheter
    4. Abbott to Present at Cowen Annual Health Care Conference
    5. Abbott Announces Required Offer to Repurchase Convertible Senior Subordinated Notes of Its AMO Subsidiary
    6. Abbott Completes Acquisition of Advanced Medical Optics
    7. Abbott Opens New Pediatric Nutrition Manufacturing Facility in Singapore
    8. Abbott Successfully Completes Tender Offer for Shares of Advanced Medical Optics
    9. Abbott Receives European Commission Clearance on Acquisition of Advanced Medical Optics
    10. Abbott Receives FDA Clearance for New CELL-DYN(R) Emerald(TM) Hematology Instrument
    11. Abbott Acquisition of Advanced Medical Optics Clears U.S. Antitrust Review
  • Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/13/2014)... The Lancet Neurology calls for sports authorities ... problems that repeated concussions can cause. , Cerebral ... traumatic brain injury (TBI), and the long-term effects ... sclerosis, and other neurological disorders, say the journal ... that even when the symptoms of concussion are ...
    (Date:7/13/2014)... in Nature Genetics identifies a novel ... causes eosinophillic esophagitis (EoE), opening up potential new ... allergy. , EoE is a chronic inflammatory ... by allergic hypersensitivity to certain foods and an ... called eosinophils (part of the body,s immune system). ...
    (Date:7/13/2014)... North American water storage systems market is estimated to grow ... at a CAGR of 21.0%, from 2013 to 2018. The ... in North America. The U.S. is experiencing high growth on ... and collection, and the increased spending on modernization and upgradation ... rate in Canada, and is rising at a rapid pace ...
    (Date:7/13/2014)... 2014 According to a new ... Market by Component (processor, GPU, DSP, connectivity), Technology ... and Geography - Forecast and Analysis to 2014-2020", ... & Computing Market is expected to reach $61.70 ... 20.75% from 2014 to 2020. , Browse 71 ...
    (Date:7/13/2014)... 2014 Athletes with a certain genetic ... concussions, according to research presented today at the American ... Meeting. The research marks the first of its kind ... known physical events that occur after a head injury. ... allele in the (GT)n genotype were four times more ...
    Breaking Medicine News(10 mins):Health News:Study finds cause of mysterious food allergy, suggests new treatment strategy 2Health News:Study finds cause of mysterious food allergy, suggests new treatment strategy 3Health News:North American Water Storage Systems Market is Expected to Reach $5,450 million by 2018 - New Report by MicroMarket Monitor 2Health News:North American Water Storage Systems Market is Expected to Reach $5,450 million by 2018 - New Report by MicroMarket Monitor 3Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Genetic Factors May Be Responsible for Slowing Concussion Recovery in Athletes 2
    ... choose and eat more indulgent food after they see someone who ... a new study in the Journal of Consumer Research . ... evening with friends and realize that they ate more and worse ... (Leeds School of Business) and Gina S. Mohr (University of Colorado, ...
    ... people are more likely to eat candy bars, whereas hopeful ... Journal of Consumer Research . That,s because when people ... us are aware that we often fall victim to emotional ... or healthy snacks when we,re feeling good?" write authors Karen ...
    ... Jason S. Meyer, Ph.D., assistant professor of biology in ... will be honored by the largest eye and vision ... day may lead to reversal of blindness caused by ... retina. The Association for Research in Vision ...
    ... By identifying a surprising association of two intracellular proteins, ... the development of new therapies to treat B cell ... B cells expressing the viral protein Latent Membrane Protein ... of cancer because of its role in the proliferation ...
    ... have shown for the first time how peppermint helps ... 20% of the population. In a paper published ... researchers from the University,s Nerve-Gut Research Laboratory explain how ... inflammatory pain in the gastrointestinal tract. Dr Stuart ...
    ... News) -- Swedish tourists who saw the most severe ... tsunami have taken longer than their peers to recover ... associated with increased levels of post-traumatic stress reactions, even ... study led by Kerstin Bergh Johannesson of Uppsala University ...
    Cached Medicine News:Health News:Does seeing overweight people make us eat more? 2Health News:Why do hopeful consumers make healthier choices than happy ones? 2Health News:IUPUI faculty member to receive national innovative vision research award 2Health News:Discovery of relationship between proteins may impact development of cancer therapies 2Health News:Peppermint earns respect in mainstream medicine 2Health News:Mental Health Effects Linger After Tsunami, Study Finds 2
    (Date:7/11/2014)... , July 11, 2014  Rock Creek Pharmaceuticals, ... company, today announced that the Food and Drug Administration ... provide comments on RCP,s Investigational New Drug ("IND") application ... trial in the US. Dr. Chris ... review and comments on our IND. When we receive ...
    (Date:7/11/2014)... , July 11, 2014  Australian drug delivery company, ... it has raised A$19.3 million via a placement of ... , the U.S., Asia ... from a share purchase plan (SPP) to be offered ... be made in two tranches. "This capital ...
    (Date:7/11/2014)... Show organisers report ... Expo 2014 were a brand new audience ... London , plus a 10% increase ...      (Logo: http://photos.prnewswire.com/prnh/20130723/629764-a) ...      (Photo: http://photos.prnewswire.com/prnh/20140711/696892-b ) ...
    Breaking Medicine Technology:Rock Creek Pharmaceuticals Issues Update On US Investigational New Drug Application 2Phosphagenics' A$19.3 million Capital Raising 2Phosphagenics' A$19.3 million Capital Raising 3UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 2UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 3UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 4
    ... SAN FRANCISCO, Calif., Feb. 9, 2011 Rigel Pharmaceuticals, ... James M. Gower, the company,s chairman and chief executive ... in New York City next week. Details of the ... ET13th Annual BIO CEO & Investor ConferencePanel Topic:  "Rheumatoid ...
    ... announces that a new market research report is ... Pacific Markets for Orthopedic Large Joint Reconstructive Devices ... In 2010, the combined markets for large ... were valued at over US$1.65 billion. ...
    Cached Medicine Technology:Rigel Announces Participation at Two Investor Conferences 2Reportlinker Adds Asia Pacific Markets for Orthopedic Large Joint Reconstructive Devices 2011 2
    Abdominal Binder w / Velcro...
    CDIs Abdominal Binders are designed with a non-pitching, body contouring, non-rolling elastic band that provides both support and compression. Available in 9, 12 and 15 widths with waist ranges from ...
    Ideal for abdominal, flank, hip and thigh procedures....
    Ideal for abdominal and flank procedures....
    Medicine Products: